US experts to scrutinise MoM hips in two-day FDA meeting
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration will be holding a two-day meeting in June to assess the risks and benefits of metal-on-metal (MoM) hip systems and evaluate potential guidelines for patients and practitioners on the use and management of these devices1,2.